""
JAMA Dermatology Publishes Data Showing upadacitinib Achieved Superiority Versus dupilumab for Primary and All Ranked Secondary Endpoints in Phase 3b Head-to-Head Study in Adults with Atopic Dermatitis 3 years ago
Energia to supply LloydsPharmacy with 100% green electricity across all of its pharmacies in Ireland 3 years ago
